A growing number of patients are filing compensation claims against manufacturers of the heartburn medication Zantac. Claims against the drug center around alleged links to various forms of cancer, leading to a surge of legal actions. The US government has also restricted the sale of Zantac, heightening concerns about its safety. Attorneys predict